Hanmi Science Co., Ltd. (KRX:008930)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceutical Wholesale Division	1.10T	1.07T	990.06B	916.53B	824.25B
Pharmaceutical Wholesale Division Growth	2.72%	8.20%	8.02%	11.20%	5.24%
Other Sectors	19.13B	15.54B	4.52B	2.10B	2.30B
Other Sectors Growth	23.10%	243.58%	115.83%	-8.88%	-19.14%
Unallocated Adjustments	-29.56B	-25.27B	-6.02B	-4.79B	-4.72B
Healthcare Business Division	129.47B	120.12B	18.45B	-	-
Healthcare Business Division Growth	7.78%	551.06%	-	-	-
Holding Sector	64.06B	66.30B	39.04B	36.33B	35.55B
Holding Sector Growth	-3.39%	69.84%	7.46%	2.19%	1.89%
Total	1.28T	1.25T	1.05T	950.16B	857.38B
Total Growth	2.85%	19.30%	10.09%	10.82%	4.99%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
South Korea	1.25T	1.21T	1.04T	944.34B	853.23B
South Korea Growth	3.00%	16.86%	9.81%	10.68%	5.15%
People's Republic of China	33.38B	33.86B	8.74B	5.82B	4.15B
People's Republic of China Growth	-1.41%	287.40%	50.24%	40.02%	-19.39%
Other	1.92B	2.23B	317.79M	3.12M	-
Other Growth	-13.79%	601.60%	10072.41%	-	-
Total	1.28T	1.25T	1.05T	950.16B	857.38B
Total Growth	2.85%	19.30%	10.09%	10.82%	4.99%

Source: S&P Global Market Intelligence.